Melissa McLaughlin

CIK: 0002127187

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)14 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALNY

ALNYLAM PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 6, 2026
Sale(S)
Direct
56 shares at avg. $320.14$18K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 6, 2026
Sale(S)
Direct
909 shares at avg. $329.76$300K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 6, 2026
Sale(S)
Direct
829 shares at avg. $330.46$274K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 6, 2026
Sale(S)
Direct
293 shares at avg. $331.89$97K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 6, 2026
Sale(S)
Direct
199 shares at avg. $333.94$66K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
224 shares at avg. $321.64$72K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
245 shares at avg. $322.86$79K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
265 shares at avg. $316.61$84K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
8 shares at avg. $325.49$3K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
81 shares at avg. $323.64$26K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
359 shares at avg. $317.44$114K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
209 shares at avg. $318.47$67K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
86 shares at avg. $319.69$27K
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Apr 2, 2026
Sale(S)
Direct
147 shares at avg. $320.62$47K

		Type	Shares	Price		Ownership
Apr 6, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	56	$320.14	$17,928	Direct
Apr 6, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	909	$329.76	$299,752	Direct
Apr 6, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	829	$330.46	$273,951	Direct
Apr 6, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	293	$331.89	$97,244	Direct
Apr 6, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	199	$333.94	$66,454	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	224	$321.64	$72,047	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	245	$322.86	$79,101	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	265	$316.61	$83,902	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	8	$325.49	$2,604	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	81	$323.64	$26,215	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	359	$317.44	$113,961	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	209	$318.47	$66,560	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	86	$319.69	$27,493	Direct
Apr 2, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Sale(S)	147	$320.62	$47,131	Direct

1-14 of 14 transactions

About McLaughlin Melissa

McLaughlin Melissa (SEC CIK 0002127187) files insider reports with the SEC as Chief Human Resources Officer of ALNYLAM PHARMACEUTICALS, INC. (ALNY).

Signal8 holds 2 ownership filings by McLaughlin Melissa (1 Form 3, 1 Form 4), filed on Apr 7, 2026. Those filings report 14 transactions, from Apr 2, 2026 to Apr 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McLaughlin Melissa's filings is in CAMBRIDGE, MA.

Recent filings by McLaughlin Melissa

Apr 6, 2026: Open-market sales of ALNY shares (5 lines, Form 4, code S).
Apr 2, 2026: Open-market sales of ALNY shares (9 lines, Form 4, code S).

Other insiders filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

SUPRAN BRYAN, EVP, CLO and Secretary
Greenstreet Yvonne, Chief Executive Officer
PYOTT DAVID E I, Director
Cravatt Benjamin, Director
Sigal Charles Elliott, Director
SCHULMAN AMY W, Director

How to read Form 4 transaction codes